List of Tables
Table 1. Global Pharma Hard Capsules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Pharma Hard Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Pharma Hard Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Pharma Hard Capsules Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pharma Hard Capsules Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Pharma Hard Capsules Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Pharma Hard Capsules Sales by Region (2020-2025) & (K Units)
Table 8. Global Pharma Hard Capsules Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Pharma Hard Capsules Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Pharma Hard Capsules Sales Share by Manufacturers (2020-2025)
Table 12. Global Pharma Hard Capsules Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Pharma Hard Capsules Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Pharma Hard Capsules by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Hard Capsules as of 2024)
Table 16. Global Pharma Hard Capsules Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Pharma Hard Capsules Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Pharma Hard Capsules Manufacturing Base and Headquarters
Table 19. Global Pharma Hard Capsules Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Pharma Hard Capsules Sales by Type (2020-2025) & (K Units)
Table 23. Global Pharma Hard Capsules Sales by Type (2026-2031) & (K Units)
Table 24. Global Pharma Hard Capsules Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Pharma Hard Capsules Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Pharma Hard Capsules ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Pharma Hard Capsules Sales by Application (2020-2025) & (K Units)
Table 29. Global Pharma Hard Capsules Sales by Application (2026-2031) & (K Units)
Table 30. Pharma Hard Capsules High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Pharma Hard Capsules Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Pharma Hard Capsules Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Pharma Hard Capsules ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Pharma Hard Capsules Growth Accelerators and Market Barriers
Table 37. North America Pharma Hard Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Pharma Hard Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Pharma Hard Capsules Growth Accelerators and Market Barriers
Table 40. Europe Pharma Hard Capsules Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Pharma Hard Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Pharma Hard Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Pharma Hard Capsules Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Pharma Hard Capsules Growth Accelerators and Market Barriers
Table 45. Southeast Asia Pharma Hard Capsules Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Pharma Hard Capsules Investment Opportunities and Key Challenges
Table 47. Central and South America Pharma Hard Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Pharma Hard Capsules Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Pharma Hard Capsules Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Lonza Corporation Information
Table 51. Lonza Description and Major Businesses
Table 52. Lonza Product Models, Descriptions and Specifications
Table 53. Lonza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Lonza Sales Value Proportion by Product in 2024
Table 55. Lonza Sales Value Proportion by Application in 2024
Table 56. Lonza Sales Value Proportion by Geographic Area in 2024
Table 57. Lonza Pharma Hard Capsules SWOT Analysis
Table 58. Lonza Recent Developments
Table 59. Qualicaps Corporation Information
Table 60. Qualicaps Description and Major Businesses
Table 61. Qualicaps Product Models, Descriptions and Specifications
Table 62. Qualicaps Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Qualicaps Sales Value Proportion by Product in 2024
Table 64. Qualicaps Sales Value Proportion by Application in 2024
Table 65. Qualicaps Sales Value Proportion by Geographic Area in 2024
Table 66. Qualicaps Pharma Hard Capsules SWOT Analysis
Table 67. Qualicaps Recent Developments
Table 68. ACG Corporation Information
Table 69. ACG Description and Major Businesses
Table 70. ACG Product Models, Descriptions and Specifications
Table 71. ACG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. ACG Sales Value Proportion by Product in 2024
Table 73. ACG Sales Value Proportion by Application in 2024
Table 74. ACG Sales Value Proportion by Geographic Area in 2024
Table 75. ACG Pharma Hard Capsules SWOT Analysis
Table 76. ACG Recent Developments
Table 77. Suheung Corporation Information
Table 78. Suheung Description and Major Businesses
Table 79. Suheung Product Models, Descriptions and Specifications
Table 80. Suheung Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Suheung Sales Value Proportion by Product in 2024
Table 82. Suheung Sales Value Proportion by Application in 2024
Table 83. Suheung Sales Value Proportion by Geographic Area in 2024
Table 84. Suheung Pharma Hard Capsules SWOT Analysis
Table 85. Suheung Recent Developments
Table 86. Farmacapsulas SA Corporation Information
Table 87. Farmacapsulas SA Description and Major Businesses
Table 88. Farmacapsulas SA Product Models, Descriptions and Specifications
Table 89. Farmacapsulas SA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Farmacapsulas SA Sales Value Proportion by Product in 2024
Table 91. Farmacapsulas SA Sales Value Proportion by Application in 2024
Table 92. Farmacapsulas SA Sales Value Proportion by Geographic Area in 2024
Table 93. Farmacapsulas SA Pharma Hard Capsules SWOT Analysis
Table 94. Farmacapsulas SA Recent Developments
Table 95. ERAWAT PHARMA LIMITED Corporation Information
Table 96. ERAWAT PHARMA LIMITED Description and Major Businesses
Table 97. ERAWAT PHARMA LIMITED Product Models, Descriptions and Specifications
Table 98. ERAWAT PHARMA LIMITED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. ERAWAT PHARMA LIMITED Recent Developments
Table 100. Dah Feng Capsule Corporation Information
Table 101. Dah Feng Capsule Description and Major Businesses
Table 102. Dah Feng Capsule Product Models, Descriptions and Specifications
Table 103. Dah Feng Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Dah Feng Capsule Recent Developments
Table 105. Lefan Capsule Corporation Information
Table 106. Lefan Capsule Description and Major Businesses
Table 107. Lefan Capsule Product Models, Descriptions and Specifications
Table 108. Lefan Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Lefan Capsule Recent Developments
Table 110. Shing Lih Fang Corporation Information
Table 111. Shing Lih Fang Description and Major Businesses
Table 112. Shing Lih Fang Product Models, Descriptions and Specifications
Table 113. Shing Lih Fang Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Shing Lih Fang Recent Developments
Table 115. Roxlor Corporation Information
Table 116. Roxlor Description and Major Businesses
Table 117. Roxlor Product Models, Descriptions and Specifications
Table 118. Roxlor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Roxlor Recent Developments
Table 120. Nectar Lifesciences Corporation Information
Table 121. Nectar Lifesciences Description and Major Businesses
Table 122. Nectar Lifesciences Product Models, Descriptions and Specifications
Table 123. Nectar Lifesciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Nectar Lifesciences Recent Developments
Table 125. Kangke Corporation Information
Table 126. Kangke Description and Major Businesses
Table 127. Kangke Product Models, Descriptions and Specifications
Table 128. Kangke Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Kangke Recent Developments
Table 130. Angtai Corporation Information
Table 131. Angtai Description and Major Businesses
Table 132. Angtai Product Models, Descriptions and Specifications
Table 133. Angtai Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Angtai Recent Developments
Table 135. Tsingtao Capsule Corporation Information
Table 136. Tsingtao Capsule Description and Major Businesses
Table 137. Tsingtao Capsule Product Models, Descriptions and Specifications
Table 138. Tsingtao Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Tsingtao Capsule Recent Developments
Table 140. Huangshan Capsule Corporation Information
Table 141. Huangshan Capsule Description and Major Businesses
Table 142. Huangshan Capsule Product Models, Descriptions and Specifications
Table 143. Huangshan Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Huangshan Capsule Recent Developments
Table 145. MEIHUA Group Corporation Information
Table 146. MEIHUA Group Description and Major Businesses
Table 147. MEIHUA Group Product Models, Descriptions and Specifications
Table 148. MEIHUA Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. MEIHUA Group Recent Developments
Table 150. Yili Capsule Corporation Information
Table 151. Yili Capsule Description and Major Businesses
Table 152. Yili Capsule Product Models, Descriptions and Specifications
Table 153. Yili Capsule Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Yili Capsule Recent Developments
Table 155. Key Raw Materials Distribution
Table 156. Raw Materials Key Suppliers
Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 158. Milestones in Production Technology Evolution
Table 159. Distributors List
Table 160. Market Trends and Market Evolution
Table 161. Market Drivers and Opportunities
Table 162. Market Challenges, Risks, and Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharma Hard Capsules Product Picture
Figure 2. Global Pharma Hard Capsules Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Stomach-soluble Gelatin Capsules Product Picture
Figure 4. Enterosoluble Vacant Gelatin Capsules Product Picture
Figure 5. Other Product Picture
Figure 6. Global Pharma Hard Capsules Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharmaceutical
Figure 8. Healthcare Products
Figure 9. Other
Figure 10. Pharma Hard Capsules Report Years Considered
Figure 11. Global Pharma Hard Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 13. Global Pharma Hard Capsules Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Pharma Hard Capsules Revenue Market Share by Region (2020-2031)
Figure 15. Global Pharma Hard Capsules Sales (2020-2031) & (K Units)
Figure 16. Global Pharma Hard Capsules Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Pharma Hard Capsules Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Pharma Hard Capsules Sales Volume Market Share in 2024
Figure 19. Global Pharma Hard Capsules Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Stomach-soluble Gelatin Capsules Revenue Market Share by Manufacturer in 2024
Figure 22. Enterosoluble Vacant Gelatin Capsules Revenue Market Share by Manufacturer in 2024
Figure 23. Other Revenue Market Share by Manufacturer in 2024
Figure 24. Global Pharma Hard Capsules Sales Market Share by Type (2020-2031)
Figure 25. Global Pharma Hard Capsules Revenue Market Share by Type (2020-2031)
Figure 26. Global Pharma Hard Capsules Sales Market Share by Application (2020-2031)
Figure 27. Global Pharma Hard Capsules Revenue Market Share by Application (2020-2031)
Figure 28. North America Pharma Hard Capsules Sales YoY (2020-2031) & (K Units)
Figure 29. North America Pharma Hard Capsules Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Pharma Hard Capsules Sales Revenue (US$ Million) in 2024
Figure 31. North America Pharma Hard Capsules Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Pharma Hard Capsules Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Pharma Hard Capsules Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Pharma Hard Capsules Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Pharma Hard Capsules Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Pharma Hard Capsules Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Pharma Hard Capsules Sales Revenue (US$ Million) in 2024
Figure 41. Europe Pharma Hard Capsules Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Pharma Hard Capsules Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Pharma Hard Capsules Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Pharma Hard Capsules Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 46. France Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Pharma Hard Capsules Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Pharma Hard Capsules Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Pharma Hard Capsules Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Pharma Hard Capsules Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Pharma Hard Capsules Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Pharma Hard Capsules Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Pharma Hard Capsules Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 61. India Pharma Hard Capsules Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Pharma Hard Capsules Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Pharma Hard Capsules Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Pharma Hard Capsules Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Pharma Hard Capsules Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Pharma Hard Capsules Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Pharma Hard Capsules Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Pharma Hard Capsules Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Pharma Hard Capsules Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Pharma Hard Capsules Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Pharma Hard Capsules Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Pharma Hard Capsules Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Pharma Hard Capsules Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Pharma Hard Capsules Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Pharma Hard Capsules Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Pharma Hard Capsules Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Pharma Hard Capsules Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Pharma Hard Capsules Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Pharma Hard Capsules Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Pharma Hard Capsules Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Pharma Hard Capsules Revenue (2020-2025) & (US$ Million)
Figure 82. Pharma Hard Capsules Industry Chain Mapping
Figure 83. Regional Pharma Hard Capsules Manufacturing Base Distribution (%)
Figure 84. Global Pharma Hard Capsules Production Market Share by Region (2020-2031)
Figure 85. Pharma Hard Capsules Production Process
Figure 86. Regional Pharma Hard Capsules Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
